Skip to main content
Log in

Pramipexole makes a difference to the QOL of patients with restless leg syndrome

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. Högl B, Poewe W, Garcia-Borreguero D, Ferini-Strambi L, Trenkwalder C.26-weeks of pramipexole on quality of life in restless legs syndrome. 13th International Congress of Parkinson's Disease and Movement Disorders: 440 abstr. Tu-315, 7 Jun 2009. Available from: URL: http://www.movementdisorders.org

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pramipexole makes a difference to the QOL of patients with restless leg syndrome. Pharmacoecon. Outcomes News 581, 10 (2009). https://doi.org/10.2165/00151234-200905810-00031

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200905810-00031

Keywords

Navigation